X. Li , J. Zhao , Y. Wang , J. Li , L. Li , X. Zheng , J. An , Y. Hua , H. Shi , W. Xu , X. Ding , Q. Wu , Y. Li , B. Cao
{"title":"54P: firmonertinib 160mg联合培美曲塞鞘内注射治疗EGFR突变伴轻脑膜转移的NSCLC患者的疗效和安全性","authors":"X. Li , J. Zhao , Y. Wang , J. Li , L. Li , X. Zheng , J. An , Y. Hua , H. Shi , W. Xu , X. Ding , Q. Wu , Y. Li , B. Cao","doi":"10.1016/S1556-0864(25)00249-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S44-S45"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"54P: Efficacy and safety of firmonertinib 160 mg combined with intrathecal injection pemetrexed in NSCLC patients with EGFR mutations and leptomeningeal metastases\",\"authors\":\"X. Li , J. Zhao , Y. Wang , J. Li , L. Li , X. Zheng , J. An , Y. Hua , H. Shi , W. Xu , X. Ding , Q. Wu , Y. Li , B. Cao\",\"doi\":\"10.1016/S1556-0864(25)00249-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"20 3\",\"pages\":\"Pages S44-S45\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086425002497\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425002497","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
54P: Efficacy and safety of firmonertinib 160 mg combined with intrathecal injection pemetrexed in NSCLC patients with EGFR mutations and leptomeningeal metastases
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.